Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-02-21
1999-11-16
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31135
Patent
active
059859326
ABSTRACT:
The present invention provides novel methods of inhibition of autoimmune diseases comprising administering to a mammal in need of treatment an effective amount of a compound of formula I ##STR1## wherein R.sup.1 and R.sup.2 may be the same or different provided that, when R.sup.1 and R.sup.2 are the same, each is a methyl or ethyl group, and, when R.sup.1 and R.sup.2 are different, one of them is a methyl or ethyl group and the other is hydrogen or a benzyl group; or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 5047431 (1991-09-01), Schickaneder et al.
patent: 5254594 (1993-10-01), Kazuaki et al.
patent: 5384332 (1995-01-01), Fontana
patent: 5389670 (1995-02-01), Fontana et al.
patent: 5441986 (1995-08-01), Thompson
patent: 5455275 (1995-10-01), Fontana
patent: 5521198 (1996-05-01), Zuckerman
patent: 5550164 (1996-08-01), Fontana
Derwent abstract No. 95-05507, Sthoeger et al. J. Rheumatol. 21, No. 12, pp. 2231-2238, 1994.
Sthoeger, Z.M., et al., "The Beneficial Effect of the Estrogen Antagonist, Tamoxifen, on Experimental Systemic Lupus Erythematosus," The Journal of Rheumatology, 1994; 12 2231-2238.
Grant, et al. Grant & Hackh's Chemical Dictionary, Fifth Edition, 1987.
Wiseman, et al., Cancer Letters, 66 (1992) 61-68 "Droloxifene (3-hydroxytamoxifen) has membrane antioxidant ability: potential relevance to its mechanism of therapeutic action in breast cancer".
Ke, et al. Bone, vol. 20, No. 1, Jan. 1997:31-39, "Comparative Effects of Droloxifene, Tamoxifen, and Estrogen on Bone, Serum Cholesterol, and Uterine Histology in the Ovariectomized Rat Model".
Hasmann, et al. Cancer Letters, 84 (1994) 101-116, "Preclinical data for Droloxifene".
Eppenberger, et al. Am J Clin Oncol, "Pharmacologic and Biologic Properties of Droloxifene, A New Antiestrogen", 1991.
MacLean David B.
Thompson David D.
Benson Gregg C.
Brokke Mervin E.
Henley III Raymond
Pfizer Inc
Richardson Peter C.
LandOfFree
Inhibition of autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1325393